Drug companies have a ‘target on their back and very few friends to protect them’ after a shift from the Trump administration. 3 could be especially at risk. http://www.businessinsider.com/trump-administration-pulling-rebate-ban-could-put-pharma-at-risk-2019-7 …

Drug companies have a ‘target on their back and very few friends to protect them’ after a shift from the Trump administration. 3 could be especially at risk. http://www.businessinsider.com/trump-administration-pulling-rebate-ban-could-put-pharma-at-risk-2019-7 …

Source: Twitter Search / businessinsider

Leave a Reply